828012125	828012125	CD	B-NP	O
|	|	NNP	I-NP	O
GMH	GMH	NNP	I-NP	O
|	|	VBD	B-VP	O
54142752	54142752	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5753062	5753062	CD	B-NP	O
|	|	CC	I-NP	O
9/29/2006	9/29/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Revasculization	Revasculization	NN	I-NP	O
of	of	IN	B-PP	O
occluded	occlude	VBN	B-NP	O
graft	graft	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/1/2006	1/1/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/27/2006	7/27/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
SLIKER	SLIKER	NN	B-NP	O
,	,	,	O	O
CESAR	CESAR	NN	B-NP	O
677-87-69-8	677-87-69-8	CD	I-NP	O
Ville	Ville	NNP	I-NP	O
Synahgarl	Synahgarl	NNP	I-NP	O
Greenpu	Greenpu	NNP	I-NP	O
Belle	Belle	NNP	I-NP	O
Burg	Burg	NNP	I-NP	O
Obrid	Obrid	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
3/8/06	3/8/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PIPES	PIPES	NNP	B-NP	O
,	,	,	O	O
HORACIO	HORACIO	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLCYSTEINE	ACETYLCYSTEINE	NN	B-NP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
100	100	CD	B-NP	O
MG/ML	MG/ML	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
600	600	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	B-VP	O
3	3	CD	B-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
ON	ON	NN	B-NP	O
DAY	DAY	NN	I-NP	O
OF	OF	IN	B-PP	O
PROCEDURE	PROCEDURE	NN	B-NP	O
.	.	.	O	O

ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	VBD	B-VP	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
CAPTOPRIL	CAPTOPRIL	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/9/06	11/9/06	CD	B-NP	O
by	by	IN	B-PP	O
BARRIENTES	BARRIENTES	NNS	B-NP	O
,	,	,	O	O
JUNIOR	JUNIOR	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
839932428	839932428	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
PLAVIX	PLAVIX	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Tomorrow	Tomorrow	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
10/9	10/9	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	O	I-protein
DIGOXIN	DIGOXIN	NN	B-NP	I-protein
0.125	0.125	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
npo	npo	NN	B-NP	B-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NN	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
125	125	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
30	30	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
ck	ck	NN	B-NP	O
FSG	FSG	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
administration	administration	NN	B-NP	O
ISORDIL	ISORDIL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
OXYCODONE	OXYCODONE	NN	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
Pain	Pain	NN	I-NP	I-protein
ROSIGLITAZONE	ROSIGLITAZONE	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
SENNA	SENNA	NN	I-NP	I-protein
TABLETS	TABLETS	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
SENNOSIDES	SENNOSIDES	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
ZOCOR	ZOCOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

SPIRONOLACTONE	SPIRONOLACTONE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/8/06	3/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
monitored	monitor	VBD	B-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
drug	drug	NN	I-NP	O
regimen	regimen	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Kenny	Kenny	NNP	B-NP	O
Freid	Freid	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
1/21/06	1/21/06	CD	I-NP	O
at	at	IN	B-PP	O
10am	10am	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Randell	Randell	NNP	B-NP	O
Jebbett	Jebbett	NNP	I-NP	O
,	,	,	O	O
MD	MD	NN	B-NP	O
after	after	IN	B-PP	O
completion	completion	NN	B-NP	O
of	of	IN	B-PP	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
VANCOMYCIN	VANCOMYCIN	NN	B-NP	O
HCL	HCL	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
with	with	IN	B-PP	O
nocturnal	nocturnal	JJ	B-NP	O
angina	angina	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Revasculization	Revasculization	NNP	I-NP	O
of	of	IN	B-PP	O
occluded	occlude	VBN	B-NP	O
graft	graft	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
3/15	3/15	CD	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
84	84	CD	I-NP	O
,	,	,	I-NP	O
96	96	CD	I-NP	O
;	;	:	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
EF	EF	NN	I-NP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
H/o	H/o	NN	I-NP	O
non-sustained	non-sustained	JJ	I-NP	O
VT	VT	NN	I-NP	O
and	and	CC	O	O
complete	complete	JJ	B-NP	O
heart	heart	NN	I-NP	O
block	block	VBP	B-VP	O
s/p	s/p	NN	B-NP	O
ICD	ICD	NN	I-NP	O
2003	2003	CD	I-NP	O
AAA	AAA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
repair	repair	NN	I-NP	O
2002	2002	CD	I-NP	O
IDDM	IDDM	NN	I-NP	O
PVD	PVD	NN	I-NP	O
HTN	HTN	NN	I-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
Spinal	Spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
severe	severe	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Chronic	Chronic	NNP	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Right	Right	NN	B-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
stent	stent	JJ	B-NP	O
x2	x2	NN	I-NP	O
to	to	TO	B-PP	O
vein	vein	NN	B-NP	O
graft	graft	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
76yoM	76yoM	NN	B-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
1997	1997	CD	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
nocturnal	nocturnal	JJ	B-NP	O
angina	angina	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
limitations	limitation	NNS	I-NP	O
of	of	IN	B-PP	O
imaging	image	VBG	B-VP	O
modalities	modality	NNS	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
MIBI/ETT	MIBI/ETT	NN	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
feasible	feasible	JJ	B-ADJP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
5/16/06	5/16/06	CD	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
catherization	catherization	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
occlusions	occlusion	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PLV	PLV	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
sized	sized	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Revascularization	Revascularization	NN	B-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
non-drug	non-drug	JJ	B-NP	O
alluding	allude	VBG	I-NP	O
stents	stent	NNS	I-NP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
original	original	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Taran	Taran	NNP	I-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
40mmHg	40mmHg	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
thoracic	thoracic	JJ	I-NP	O
aorta	aorta	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
femoral	femoral	JJ	I-NP	O
aorta	aorta	NN	I-NP	O
raising	raise	VBG	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
Mr.	Mr.	NNP	B-NP	O
Mcconnell	Mcconnell	NNP	I-NP	O
's	's	POS	B-NP	O
severe	severe	JJ	I-NP	O
lower	low	JJR	I-NP	O
back	back	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
limited	limit	VBN	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Plavix	Plavix	NNP	B-NP	O
x	x	CC	O	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	I-NP	O
Aspirin	Aspirin	NN	I-NP	O
indefinately	indefinately	RB	B-VP	O
following	follow	VBG	I-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
Metoprolol	Metoprolol	NNP	B-NP	O
,	,	,	O	O
Isordil	Isordil	NNP	B-NP	O
,	,	,	O	O
Digoxin	Digoxin	NNP	B-NP	O
,	,	,	O	O
Spironalactone	Spironalactone	NNP	B-NP	O
,	,	,	O	O
Insulin	Insulin	NNP	B-NP	B-protein
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
and	and	CC	O	O
prn	prn	VB	B-VP	O
Nitroglycerin	Nitroglycerin	NNP	B-NP	O
.	.	.	O	O

Groin	Groin	NN	B-NP	O
sheaths	sheath	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
or	or	CC	I-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
and	and	CC	O	O
stable	stable	JJ	B-NP	O
vitals	vital	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
recur	recur	VB	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
confortably	confortably	RB	B-ADVP	O
without	without	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
Aspirin	Aspirin	NN	I-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Aspirin	Aspirin	NN	I-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
term	term	NN	I-NP	O
basis	basis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Plavix	Plavix	NNP	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
for	for	IN	B-PP	O
ATLEAST	ATLEAST	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
WEEKS	WEEKS	NN	I-NP	I-protein
from	from	IN	B-PP	O
10/29	10/29	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
Cardiologist	Cardiologist	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Golaszewski	Golaszewski	NNP	I-NP	O
Please	Please	NNP	I-NP	O
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
Plavix	Plavix	NNP	I-NP	O
75mg	75mg	NN	I-NP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
-LRB-	-LRB-	JJ	B-ADJP	B-protein
until	until	IN	B-PP	I-protein
atleast	atleast	NN	B-NP	I-protein
3/12/06	3/12/06	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
Aspirin	Aspirin	NN	I-NP	O
325mg	325mg	NN	I-NP	O
indefinately	indefinately	RB	B-NP	O
Please	Please	NN	I-NP	O
reschedule	reschedule	NN	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kuick	Kuick	NNP	I-NP	O
to	to	TO	B-VP	O
receive	receive	VB	I-VP	O
steroid	steroid	NN	B-NP	O
injections	injection	NNS	I-NP	O
for	for	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
until	until	IN	B-PP	O
AFTER	AFTER	NN	B-NP	O
your	your	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
is	be	VBZ	B-VP	O
complete	complete	JJ	B-ADJP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
YUEH	YUEH	NNP	B-NP	O
,	,	,	O	O
EARL	EARL	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NQ38	NQ38	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/8/06	3/8/06	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

